CRIS Current Research Information System

MAZZELLA, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.102
AS - Asia 10.657
EU - Europa 7.529
AF - Africa 612
SA - Sud America 504
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 3
Totale 31.425
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.965
VN - Vietnam 3.725
SG - Singapore 2.703
CN - Cina 2.217
GB - Regno Unito 2.004
IT - Italia 1.069
DE - Germania 965
SE - Svezia 849
HK - Hong Kong 568
FR - Francia 536
IN - India 495
RU - Federazione Russa 443
UA - Ucraina 409
BR - Brasile 355
IE - Irlanda 309
NL - Olanda 253
ZA - Sudafrica 193
JP - Giappone 185
BD - Bangladesh 174
EE - Estonia 160
CI - Costa d'Avorio 157
KR - Corea 135
CH - Svizzera 109
FI - Finlandia 102
TG - Togo 91
CA - Canada 86
BG - Bulgaria 68
PH - Filippine 62
SC - Seychelles 61
AR - Argentina 56
PL - Polonia 50
TH - Thailandia 49
JO - Giordania 48
ID - Indonesia 41
NG - Nigeria 40
GR - Grecia 38
BE - Belgio 36
AT - Austria 35
EC - Ecuador 35
TR - Turchia 35
TW - Taiwan 35
IQ - Iraq 31
PK - Pakistan 31
MX - Messico 30
ES - Italia 26
IR - Iran 22
SA - Arabia Saudita 21
EG - Egitto 16
AU - Australia 14
LB - Libano 14
LT - Lituania 11
MY - Malesia 11
PE - Perù 11
UZ - Uzbekistan 11
CL - Cile 10
CO - Colombia 9
CZ - Repubblica Ceca 9
ET - Etiopia 9
VE - Venezuela 9
IL - Israele 8
KE - Kenya 8
MA - Marocco 8
PY - Paraguay 8
DZ - Algeria 7
RO - Romania 7
TN - Tunisia 7
DK - Danimarca 6
SI - Slovenia 6
BO - Bolivia 5
HR - Croazia 5
PT - Portogallo 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
AO - Angola 4
KW - Kuwait 4
MD - Moldavia 4
MK - Macedonia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
BB - Barbados 3
BH - Bahrain 3
JM - Giamaica 3
LK - Sri Lanka 3
MM - Myanmar 3
NI - Nicaragua 3
NP - Nepal 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BF - Burkina Faso 2
DO - Repubblica Dominicana 2
EU - Europa 2
HN - Honduras 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LY - Libia 2
VG - Isole Vergini Britanniche 2
BA - Bosnia-Erzegovina 1
BW - Botswana 1
Totale 31.404
Salva come PNG Salva come JPEG
Città #
Singapore 1.881
Southend 1.800
Fairfield 1.358
Ashburn 1.225
Chandler 854
Ho Chi Minh City 837
Hanoi 745
San Jose 609
Hong Kong 536
Wilmington 515
Woodbridge 502
Santa Clara 501
Houston 484
Seattle 472
Dong Ket 439
Princeton 387
Cambridge 370
Dublin 307
Ann Arbor 303
Boardman 284
Beijing 269
Jacksonville 241
Bologna 230
Hefei 208
Lauterbourg 189
Nanjing 181
Westminster 177
New York 167
Los Angeles 163
Abidjan 157
Tokyo 154
Padova 149
Dallas 122
Da Nang 119
Council Bluffs 118
Saint Petersburg 115
Berlin 111
Haiphong 110
Buffalo 106
Lomé 91
Milan 89
Medford 88
Seoul 85
Bern 78
Helsinki 77
Jinan 76
Shenyang 75
Frankfurt am Main 74
Dearborn 67
Hebei 64
Sofia 62
São Paulo 62
San Diego 61
Changsha 59
Biên Hòa 56
Nanchang 56
Munich 52
Shanghai 52
Hải Dương 49
Amman 48
Thái Nguyên 48
Guangzhou 47
Bremen 45
Ha Long 45
Redondo Beach 45
Quận Bình Thạnh 44
Can Tho 42
Florence 41
Mülheim 41
Abeokuta 39
Tianjin 38
Des Moines 37
Bắc Ninh 33
Turin 32
Zhengzhou 32
Brussels 31
Chicago 31
Johannesburg 31
London 31
Falkenstein 29
Hangzhou 29
Mahé 29
Jiaxing 28
Phoenix 28
Redwood City 28
Toronto 28
Ninh Bình 26
Pune 26
Falls Church 25
Redmond 25
Bắc Giang 24
Orem 24
Vinh 24
Wuhan 24
Amsterdam 23
San Francisco 23
Turku 23
Warsaw 23
Xi'an 23
Yubileyny 23
Totale 20.184
Salva come PNG Salva come JPEG
Nome #
G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence 614
G-CSF administration is not related to PEG-IFN alfa-213 treatment duration nor response in liver transplanted patients with HCV recurrence 518
Antiinflammatory Effect of Phytosterols in Experimental Murine Colitis Model: Prevention, Induction, Remission Study 498
Outcomes and survival after TIPS positioning: a single center experience 407
Two cases of severe autoimmune manifestations following virological response to peginterferon alpha- 2b + ribavirin in liver transplanted patients with recurrence of chronic hepatitis C 339
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 328
A new model for portal protein profile analysis in course of ileal intraluminal bile acid infusion using an in situ perfused rat intestine. 304
Adefovir and lamivudine combination therapy is superior to ADV monotherapy for lamivudine-resistant patients with HBeAG-negative chronic hepatitis B 303
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 278
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. 256
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 255
Curcuma longa Extract Exerts a Myorelaxant Effect on the Ileum and Colon in a Mouse Experimental Colitis Model, Independent of the Anti-Inflammatory Effect 255
G-CSF administration is not related to Peg-IFN alfa-2b treatment duration nor response in liver transplanted patients with HCV recurrence. 245
Berberine and its metabolites: Relationship between physicochemical properties and plasma levels after administration to human subjects 243
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 237
AISF position paper on liver disease and pregnancy 226
Curcuma longa L. as a therapeutic agent in intestinal motility disorders. 2: Safety profile in mouse. 225
The future of dual therapy for hepatitis C virus 223
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 222
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica 221
Adverse effects of proton pump inhibitors. 219
Complete Remission of Advanced Hepatocellular Carcinoma Treated with Sorafenib and Concomitant Appearance of IgG4- related Diseases. A Case Report 219
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 218
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 217
High Doses of Ursodeoxycholic Acid Up-Regulate the Expression of Placental Breast Cancer Resistance Protein in Patients Affected by Intrahepatic Cholestasis of Pregnancy 217
Utility of Doppler-Ultrasound and Liver Elastography in the Evaluation of Patients with Suspected Pregnancy-Related Liver Disease 216
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. 216
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 216
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 213
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 212
Generation of a novel antibody probe to the Apical Sodium-Dependent Bile Acid Transporter that inhibits ileal bile acid absorption 211
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 207
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 206
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 205
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 204
Alisporivir for the treatment of chronic HCV 202
Interleukin 28 polymorphisms and hepatocellular carcinoma development after direct acting antiviral therapy for chronihepatitis c 202
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 200
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis 199
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 199
The impact of assisted reproductive technology and chorionicity in twin pregnancies complicated by obstetric cholestasis 198
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis 194
Ribavirin for chronic hepatitis C: And the mystery goes on. 192
Severe immune thrombocytopenia after peg-interferonalpha2a, ribavirin and telaprevir treatment completion: A case report and systematic review of literature 189
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 189
IL28 polymorphism and HCC after DAAs for chronic hepatitis C 184
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 184
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 182
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent. 180
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 179
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 179
High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? 178
Colonic gallstone ileus treated with radiologically guided xtracorporeal shock wave lithotripsy followed by endoscopic extraction. 176
Small (≤3cm) Hepatocellular Carcinoma in Cirrhosis: the Role of Double Contrast Agents MR Imaging vs. Multi-Detector Row CT 175
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 175
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 175
Terapia cellulare in Epatologia 174
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 174
Pharmacological modulation of MRP2 in primary biliary cirrhosis 173
Ductal stones recurrence after extracorporeal shock wave lithotripsy for difficult common bile duct stones: Predictive factors 173
Efficacy of ursodeoxycholic acid administration on clinical manifestations of gallstones and gastrointestinal motility 170
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 170
Correlation between Indocyanine green retention test and esophageal varices among patients with hepatocellular carcinoma 168
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 168
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study 165
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices 165
Orthotopic liver transplantation (OLT): contribution of imaging and interventional radiology in preparing the transplantation and managing complications. Part 2: post-OLT complications and their treatment. 164
Regolazione dei trasportatori placentari degli acidi biliari MRP2, MRP3, MRP4 da parte dell’acido ursodesossicolico in corso di colestasi gravidica 164
Proton pump inhibitors in cirrhosis: tradition or evidence based practice? 164
Superior efficacy of twice a week administration of peginterferon alpha-2b plus ribavirin in obtaining SVR in HCV genotype 1 163
Chronic NSAIDs Therapy and Upper Gastrointestinal Tract – Mechanism of Injury, Mucosal Defense, Risk Factors for Complication Development and Clinical Management 163
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis 163
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 163
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project). 163
Indocyanine Green 15-min Retention test (ICG-r15) as a predictor of clinical decompensation in patients with compensated liver cirrhosis. 163
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 163
Persistent Fever and Abdominal Pain in a Young Woman With Budd-Chiari Syndrome 161
Indocyanine green clearance (ICG) as a predictor of 2-years clinical decompensation and mortality in patients with compensated liver cirrhosis 160
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 159
Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update 159
Indocyanine Green Clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis 159
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial 159
Fatty liver in pregnancy: a narrative review of two distinct conditions 159
A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis 158
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis 158
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 157
Orthotopic liver transplantation (OLT): contribution of diagnostic imaging and interventional radiology in preparing the transplantation and managing complications. Part 1: Indications, surgical technique, diagnostic imaging and interventional radiology before transplantation from cadaveric and living donor. 156
An unusual cause of weight loss in a young Caucasian man 156
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 156
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 156
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 155
Noninvasive diagnosis of portal hypertension and esophageal varices through the identification of liver blood flow markers 155
Indocyanine green clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis. 155
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 155
Chemiluminescence measurement of autotaxin activity in human serum 154
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial 154
MRP2 is upregulated by UDCA in cholestasis of pregnancy. 152
P.09.6 IL28 POLYMORPHISM AND HCC DEVELOPMENT AFTER DAAS FOR CHRONIC HEPATITIS C 152
Breath tests with stable isotopes: have they a role in liver transplantation? 150
Imaging Features of Microvascular Invasion in Hepatocellular Carcinoma Developed in HCV-Related Cirrhosis after Direct-Acting Antiviral Therapy. 150
Totale 20.402
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.868
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.868
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021762 0 0 0 0 0 0 0 0 0 0 0 762
2021/20223.802 325 146 205 235 332 196 88 204 138 171 1.187 575
2022/20233.493 420 491 200 468 232 273 92 177 612 85 240 203
2023/20241.004 70 162 58 121 83 243 37 52 71 60 21 26
2024/20253.863 153 684 354 240 679 179 215 96 43 332 147 741
2025/202610.811 1.995 765 784 567 1.052 542 929 387 2.081 747 634 328
Totale 31.888